PCMK
NEO icon

Paragon Capital Management (Kansas)’s NeoGenomics NEO Stock Holding History

Paragon Capital Management (Kansas)’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-250
Closed -$7K – 124
2020
Q1 		$7K Buy
+250
New +$7.49K 0.01% 150
2019
Q3 		– Sell
-250
Closed -$5K – 158
2019
Q2 		$5K Buy
+250
New +$5.49K ﹤0.01% 186

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
KFO
Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Paragon Capital Management (Kansas)'s NEO Position: Q2 2020 in Review

Paragon Capital Management (Kansas) sold out of NeoGenomics (NEO) in Q2 2020, closing a stake of 250 shares — an estimated $7K sold.

Paragon Capital Management (Kansas) first reported a position in NEO in Q2 2019 and held it in 2 quarters. The position peaked at $7K in Q1 2020. 285 funds tracked by Wall St. Rank hold NEO as of Q2 2020.

  • Paragon Capital Management (Kansas) reported no remaining NeoGenomics position as of Q2 2020 after selling out during the quarter.
  • Paragon Capital Management (Kansas) sold 250 NeoGenomics shares in Q2 2020, an estimated $7K.
  • Paragon Capital Management (Kansas) first reported a position in NeoGenomics in Q2 2019 and held it in 2 quarters.
  • Paragon Capital Management (Kansas)'s NeoGenomics position peaked at $7K in Q1 2020.
  • 285 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2020.

Based on Paragon Capital Management (Kansas)'s 13F filing for Q2 2020, filed 3 Aug 2020.